Home/Contractors/We Pharma, INC.

Federal Contractor Profile

We Pharma, INC.

Federal contracting record: $5.8M obligated across 22 awards from 1 agencies, FY 2018–2025.

$5.8M
Total Obligated
22
Award Records
1
Agencies Served
4
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

UEI (Unique Entity Identifier)

EWAMVJSFNK29

CAGE Code

7CN54

Parent Organization

We Pharma, INC.

Address

951 AVIATION PKWY STE 200, MORRISVILLE, NC, 275606637

First Federal Award

Jan 31, 2018

Most Recent Award

Sep 16, 2025

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Health and Human Services

    22 awards · 100.0% of total

    $5.8M

Top NAICS Activity

  • 424210

    DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS

    6 awards

    $2.9M

  • 325412

    PHARMACEUTICAL PREPARATION MANUFACTURING

    13 awards

    $2.8M

  • 339113

    SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING

    2 awards

    $49K

  • 339112

    SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING

    1 awards

    $15K

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Sep 16, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.$300K
Jul 28, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS424210TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR).$607K
May 14, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHARMACEUTICAL DRUG PRODUCTS$75K
Apr 25, 2024Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412TASK ORDER AGAINST IDIQ 75F40120D00032 FOR PHARMACEUTICAL DRUG PRODUCTS.$357K
Feb 28, 2024Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS424210TASK ORDER$500K
Jul 31, 2023Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHARMACEUTICAL DRUG PRODUCT ORDERS$410K
Mar 23, 2023Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS424210PHARMACEUTICAL PRODUCTS FOR FDA/OPQ DOMESTIC MANUFACTURING AND REGULATORY PURPOSES.$240K
Mar 6, 2023Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS424210TASK ORDER$500K
Dec 23, 2022Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHARMACEUTICAL DRUG PRODUCTS$183K
Aug 4, 2022Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS424210TASK ORDER$500K
Jun 15, 2022Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS424210PHARMACEUTICAL PRODUCTS FOR FDA/OPQ DOMESTIC MANUFACTURING$150K
Dec 2, 2021Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412THE PURPOSE AND OBJECTIVES OF THIS REQUIREMENT IS TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.$100K
Sep 11, 2021Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF TESTING RESEARCH IN ST. LOUIS, MO.$500K
Aug 2, 2021Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS424210TASK ORDER$500K
Sep 30, 2020Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412THE PURPOSE AND OBJECTIVES OF THIS REQUIREMENT IS TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES$250K
Sep 30, 2020Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412THE PURPOSE AND OBJECTIVES OF THIS REQUIREMENT IS TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.$250K
Sep 30, 2020Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412THE PURPOSE AND OBJECTIVES OF THIS REQUIREMENT IS TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.$178K
Feb 14, 2019Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHYSICOCHEMICAL PRODUCTS$50K
Dec 18, 2018Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHYSICOCHEMICAL PRODUCTS$35K
Sep 5, 2018Department of Health and Human ServicesPROGRAM SUPPORT CTR SUPPLY SVC CTR339113FDA/DPA ST LOUIS$44K
Aug 23, 2018Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHARMACEUTICAL PRODUCTS$19K
Aug 13, 2018Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHYSICOCHEMICAL PRODUCTS$100K
Jun 29, 2018Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS325412PHYSICOCHEMICAL PRODUCTS$30K
Jun 18, 2018Department of Health and Human ServicesPROGRAM SUPPORT CTR SUPPLY SVC CTR339112FDA DROPSHIP$15K
Jan 31, 2018Department of Health and Human ServicesPROGRAM SUPPORT CTR SUPPLY SVC CTR339113FDA-DPA DROPSHIP$5K

Related Contractors

Other companies active in NAICS 424210 — DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS.

Amerisourcebergen Drug Corp

$7.0B

Dms Pharmaceutical Group INC

$791M

Mckesson Corporation

$31M

Dakota Drug, INC.

$26M

Mckesson Corporation

$18M

Priority Healthcare Distribution INC

$1.3M

A-s Medication Solutions LLC

$641K

Ase Direct, INC.

$611K

Track We Pharma, INC. Recompetes Before They Post

Mindy monitors We Pharma, INC.'s active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts